ConclusionĢ4% of e-prescriptions for new medications were not filled. 001) Nonadherence occurred less often when e-prescriptions were transmitted directly to the pharmacy rather than printed to give to patients (OR 0.54 95% CI, 0.52-0.57 P <.
001) and residence in a low-income ZIP code (OR 1.23 compared with high-income ZIP code 95% CI, 1.17-1.30 P <. Several factors were associated with nonadherence to e-prescriptions, including nonformulary status of medications (odds ratio 1.31 compared with preferred medications 95% confidence interval, 1.26-1.36 P <. We identified 423,616 e-prescriptions for new medications, with 3634 prescribers and 280,081 patients. We evaluated the rate of primary nonadherence to newly prescribed medications across multiple characteristics of patients, prescribers, and prescriptions and developed multivariable models to identify predictors of nonadherence. We matched e-prescriptions with filled claims by using data on the drug name, date of e-prescription, and date of filled claims, allowing up to 180 days for patients to fill e-prescriptions. We analyzed e-prescribing data and filled claims for all patients with CVS Caremark (Woonsocket, RI) drug coverage who received e-prescriptions from the iScribe e-prescribing system in calendar 2008. The advent of electronic prescribing (e-prescribing) systems provides the opportunity to track initial prescriptions and identify nonadherence that may have previously been undetected. Most adherence studies evaluate behavior only among patients who have filled a first prescription. Working directly with Allscripts in this next phase will strengthen our ability to deliver scalable e-prescribing solutions, which include valuable information, to meet our clients’ business and clinical goals.Patient nonadherence to prescribed medication is common and limits the effectiveness of treatment for many conditions. In postmenopausal women, Ibrance is given in combination with a hormonal medicine such as letrozole ( Femara ). Ibrance is used in men and women to treat HR-positive, HER2-negative breast cancer that has spread to other parts of the body. “We helped define this market through our participation as one of the founders of the Surescripts network, which connects prescribers to critical prescribing information and the pharmacy, and as an early provider of e-prescribing tools. Ibrance is a cancer medicine that interferes with the growth and spread of cancer cells in the body. “This represents a natural progression of our work in the expanding e-prescribing industry,” said Troyen Brennan, MD, executive vice president and CMO of CVS Caremark. The Centers for Medicare and Medicaid Services also provides financial incentives for e-prescribing under the Medicare Improvements for Patients and Providers Act.
Providers who qualify for incentive funds in the first stage stand to gain between $44,000 and $64,000 beginning in 2011.
Under the agreement, Allscripts will offer providers an upgrade to a full EHR, which officials say would also help them qualify for “meaningful use” of IT and incentive funds allocated under the American Recovery and Reinvestment Act. “Electronic prescribing is a proven technology that can improve health outcomes by reducing medication errors, leading to lower healthcare costs,” said Glen Tullman, Allscripts' CEO.ĬVS Caremark, based in Woonsocket, R.I., will transition providers using the company’s iScribe e-prescribing tool to the new Allscripts e-prescribing tool, then retire the iScribe solution.ĬVS officials said this could be a first step toward adoption of a full electronic health record, which provides e-prescribing capabilities and automation of other everyday clinical tasks. The agreement with Allscripts, a Chicago-based provider of e-prescribing and electronic health record solutions, is expected to assist the nation's largest pharmacy healthcare provider in supporting its payer and employer clients and driving e-prescribing throughout their networks. The inclusion of electronic prescribing in the Medicare Modernization Act (MMA) of 2003 gave momentum to the. CVS Caremark has announced an agreement with Allscripts-Misys Healthcare Solutions to replace its own e-prescribing solution with the Allscripts model. E-Prescribing is a prescribers ability to electronically send an accurate, error-free and understandable prescription directly to a pharmacy from the point-of-care - is an important element in improving the quality of patient care.